Back
Enliven Therapeutics Vs. Phathom Pharmaceuticals Industry Stock Comparison
Buy
58
ELVN
Enliven Therapeutics
Last Price:
27.82
Seasonality Move:
-12%
Buy
55
PHAT
Phathom Pharmaceuticals
Last Price:
17.12
Seasonality Move:
-5.28%
Buy
58
Enliven Therapeutics (ELVN)
is a Buy
Is Enliven Therapeutics a Buy, Sell or Hold?
- The current Enliven Therapeutics [ELVN] share price is $28.38. The Score for ELVN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- ELVN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $17.42. The Score for PHAT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ELVN Stock Price Chart
What is Enliven Therapeutics's stock price today?
-
The Enliven Therapeutics share price today is $28.38
The current trend is moderately bullish and ELVN is experiencing slight selling pressure.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $17.42
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing slight buying pressure.
ELVN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.04 | Buy |
Relative Strength Index (14 RSI): | 62.6 | Buy |
Chaikin Money Flow: | -29113 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.01 - 28.99) | Buy |
Bollinger Bands (100): | (21.59 - 26.47) | Buy |
PHAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 56.88 | Buy |
Chaikin Money Flow: | 57222 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.76 - 17.5) | Buy |
Bollinger Bands (100): | (11.07 - 16.99) | Buy |
ELVN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.77 | Sell |
20-day SMA: | 28.12 | Buy |
50-day SMA: | 25.08 | Buy |
200-day SMA: | 21.13 | Buy |
8-day EMA: | 28.56 | Sell |
20-day EMA: | 27.79 | Buy |
50-day EMA: | 25.97 | Buy |
200-day EMA: | 21.93 | Buy |
PHAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.6 | Buy |
20-day SMA: | 16.38 | Buy |
50-day SMA: | 16.73 | Buy |
200-day SMA: | 11.65 | Buy |
8-day EMA: | 16.79 | Buy |
20-day EMA: | 16.61 | Buy |
50-day EMA: | 16.03 | Buy |
200-day EMA: | 12.92 | Buy |
Enliven Therapeutics Earnings Growth & ELVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.48 per share.
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
Enliven Therapeutics Technical Analysis
Oct 17 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Phathom Pharmaceuticals Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |